Search Tenders

Tenders For denosumab

Ref No Posting Date Deadline Location Value Short Description
1979116250630 30-Jun-2025 09-Jul-2025 Brazil Refer Document. Tender For Acquisition of high-cost drugs (Special Drug Program)
View Tender Detail
6617816250628 28-Jun-2025 07-Jul-2025 Chile Refer Document. Tender For MEDICATION SUPPLY SERVICE
View Tender Detail
3357216250627 27-Jun-2025 10-Jul-2025 India / MADHYA PRADESH Refer Document. Tender For DENOSUMAB 120 MG INJECTION
View Tender Detail
3386616250627 27-Jun-2025 07-Jul-2025 India / punjab Refer Document. Tender For Inj. Denosumab 120mg
View Tender Detail
3607016250627 27-Jun-2025 14-Jul-2025 Brazil Refer Document. Tender For acquisitions of various medications
View Tender Detail
1812316250624 24-Jun-2025 11-Jul-2025 India / punjab Refer Document. Tender For DENOSUMAB 60 MG INJECTION.
View Tender Detail
1464217250618 18-Jun-2025 16-Jul-2025 India / Uttar Pradesh Refer Document. Tender For INJ. DENOSUMAB 120 MG PER UNIT
View Tender Detail
1685817250618 18-Jun-2025 01-Jul-2025 India / Telangana Refer Document. Tender For DENOSUMAB 120 MG INJ.
View Tender Detail
2082117250618 18-Jun-2025 18-Jul-2025 Czech Republic Refer Document. Tender For Medicinal products containing denosumab
View Tender Detail
487417250614 14-Jun-2025 03-Jul-2025 Chile Refer Document. Tender For Alendronate sodium
View Tender Detail
572817250611 11-Jun-2025 09-Jul-2025 Czech Republic Refer Document. Tender For Drug deliveries PROLIA 2025
View Tender Detail
9142416250521 21-May-2025 30-Apr-2027 Germany Refer Document. Tender For Open house drug discount agreements for the active ingredient denosumab, trade name Xgeva
View Tender Detail
9155616250521 21-May-2025 30-Apr-2027 Germany Refer Document. Tender For active ingredient denosumab, trade name Prolia
View Tender Detail
9163416250521 21-May-2025 30-Apr-2027 Germany Refer Document. Tender For Pharmaceutical products
View Tender Detail
1963616250520 20-May-2025 30-Apr-2027 Germany Refer Document. Tender For Open house drug discount agreements for the active ingredient denosumab
View Tender Detail

» Our Top Clients